
1. malar j. 2019 sep 24;18(1):328. doi: 10.1186/s12936-019-2966-9.

duffy antigen receptor chemokines gene polymorphisms malaria in
mangaluru, india.

gai pp(1), van loon w(2), siegert k(2), wedam j(2), kulkarni ss(3), rasalkar
r(3), boloor a(4)(5), kumar a(6), jain a(4)(5), mahabala c(4)(5), baliga s(4)(5),
devi r(7), shenoy d(4)(5), gai p(3), mockenhaupt fp(2).

author information: 
(1)charité-universitätsmedizin berlin, corporate member freie universität
berlin, humboldt-universität zu berlin, berlin institute health; institute
of tropical medicine international health, berlin, germany.
prabhanjangai@hotmail.com.
(2)charité-universitätsmedizin berlin, corporate member freie universität
berlin, humboldt-universität zu berlin, berlin institute health; institute
of tropical medicine international health, berlin, germany.
(3)karnataka institute dna research, dharwad, karnataka, india.
(4)kasturba medical college, mangalore, india.
(5)manipal academy higher education, manipal, karnataka, india.
(6)district vector borne disease control programme office, dakshina kannada,
mangaluru, karnataka, india.
(7)wenlock hospital, mangaluru, karnataka, india.

background: duffy blood group antigens serve receptors plasmodium vivax
invasion erythrocytes, determined polymorphisms duffy
antigen receptor chemokines (darc), also known fy glycoprotein (fy). duffy
negativity, i.e., absence antigens, protects p. vivax infection
and rare among non-african populations. however, data darc polymorphisms
and impact plasmodium infection india scarce.
methods: case-control study among 909 malaria patients 909 healthy
community controls mangaluru, southwestern india, darc polymorphisms t-33c
(rs2814778), g125a (rs12075), c265t (rs34599082), g298a (rs13962) were
genotyped. associations polymorphisms odds malaria, parasite
species manifestation assessed.
results: among patients, vivax malaria (70%) predominated falciparum malaria
(9%) mixed species infections (21%). darc t-33c absent c265t rare
(1%). fyb carriage (deduced darc g125a) associated risk 
malaria per se protected severe falciparum malaria (p = 0.03), and
hospitalization (p = 0.006) due falciparum malaria. vice versa, carriage of
darc 298a associated increased odds malaria (aor, 1.46 (1.07-1.99),
p = 0.015) vivax malaria (aor, 1.60 (1.14-2.22), p = 0.006) several 
reported symptoms findings patients.
conclusion: report southern india first show independent
effect darc 298a polymorphism risk malaria. functional studies
are required understand underlying mechanism. moreover, fyb carriage
appears protect severe falciparum malaria southern india.

doi: 10.1186/s12936-019-2966-9 
pmcid: pmc6760058
pmid: 31551092  [indexed medline]

